EAST Trial
STUDY OBJECTIVE
The EAST trial is to test whether an early, comprehensive, rhythm control therapy can prevent adverse cardiovascular outcomes in patients with atrial fibrillation (AF) compared to usual care.
BE, CZ, FR, DE, GB, IT, NL, PL, ES
EAST is registered at ClinicalTrials.gov, ISRTCN, and EU Clinical Trials Register
ClinicalTrials.gov: NCT01288352
http://clinicaltrials.gov/ct2/show/NCT01288352?term=NCT01288352&rank=1
ISRCTN04708680
http://www.controlled-trials.com/ISRCTN04708680/ISRCTN04708680
EU Clinical Trials Register
https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-021258-20
© by east - early treatment of atrial fibrillation for stroke prevention trial
EAST - AN AFNET / EHRA TRIAL
Counter
Active centers: 70
Top recruiting centers
Belgium:
1. Hosp Aalst: 11 pts
2. Hosp Maaseik: 9 pts
2. CHU Leuven: 8 pts
Czech Republic:
1. Univ Hosp Prague: 3 pts
2. Hosp IKEM Prague: 2 pts
France:
1. CHU Nancy: 1 pt
1. Hosp Neuilly sur Seine: 1 pt
Germany:
1. Dr. Schön, Mühldorf: 103 pts
2. Univ Hosp Bonn: 55 pts
3. Marienhosp Bonn: 45 pts
Italy:
1. Univ Hosp Rome La Sapienza: 4 pts
2. Hosp Reggio Emilia: 3 pts
Netherlands:
1. Hosp Zwolle: 30 pts
2. Hosp Zutphen: 29 pts
3. Hosp Harderwijk: 10 pts
Poland:
1. Hosp WSPRITS Warsaw: 16 pts
2. Hosp National Institute of Cardiology Warsaw: 6 pts
Spain:
1. Univ Hosp Barcelona: 5 pts
2. Univ Hosp Madrid Ramon y Cajal: 2 pts
3. Hosp Barcelana del Mar: 1 pt
United Kingdom:
1. Hosp Birmingham City: 6 pts
1. Hosp Kettering: 6 pts
2. Hosp Grantham: 2 pts
Status: 17.05.2013
News
05.12.2012
|
500 patients enrolled
12.07.2012
|
300 patients enrolled
25.03.2012
|
150 patients randomized